Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

CDK2AP2 leads to the methylation of TP53. 1 / 3

| 1

➶

reach

"Of note, abnormalities reported in our review are minored by not taking into account epigenetic modifications, for instance ARF promoter hypermethylation in DLBCL, or TP53 promoter hypermethylation in[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

28284458

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...